QA: Idexx Laboratories INC DE in us_medicinal_products/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000874716_2025_Idexx_Laboratories_INC_DE.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.36630960470269536, 'aggregate_val': 3350759000, 'exp_sum': 5287691000, 'exp_to_value': {'AssetsCurrent': 1413827000, 'AssetsNoncurrent': 1936932000, 'PropertyPlantAndEquipmentNet': 747380000, 'Goodwill': 523847000, 'remainder_Assets': 665705000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.2547300569015918, 'aggregate_val': 1745376000, 'exp_sum': 2341938000, 'exp_to_value': {'LiabilitiesNoncurrent': 596562000, 'LiabilitiesCurrent': 1180679000, 'remainder_Liabilities': 564697000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.3650568759640709, 'aggregate_val': 3293443000, 'exp_sum': 5186989000, 'exp_to_value': {'AssetsCurrent': 1399897000, 'AssetsNoncurrent': 1893546000, 'PropertyPlantAndEquipmentNet': 713123000, 'Goodwill': 516776000, 'remainder_Assets': 663647000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.27067048511731945, 'aggregate_val': 1698130000, 'exp_sum': 2328344000, 'exp_to_value': {'LiabilitiesNoncurrent': 630214000, 'LiabilitiesCurrent': 1079228000, 'remainder_Liabilities': 618902000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000874716, Idexx Laboratories INC DE

  xvar xval
0 LiabilitiesNoncurrent 630,214,000
1 LiabilitiesCurrent 1,079,228,000
2 remainder_Liabilities -11,312,000
3 AssetsCurrent 1,399,897,000
4 AssetsNoncurrent 1,893,546,000
5 PropertyPlantAndEquipmentNet 713,123,000
6 Goodwill 516,776,000
7 remainder_Assets -1,229,899,000
8 GeneralAndAdministrativeExpense 2,549,375,000
9 ResearchAndDevelopmentExpense 219,792,000
10 remainder_Expenses 253,169,000
11 remainder_Revenues 3,910,203,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -22,439,000
  yvar yval
0 Liabilities 1,698,130,000
1 Assets 3,293,443,000
2 Expenses 3,022,336,000
3 Revenues 3,910,203,000
4 StockholdersEquity 1,595,313,000
5 NetIncome 887,867,000
6 ComprehensiveNetIncome 876,647,500
7 BaseVar 5,973,275,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.23
9 EconomicCapitalRatio 1.83

Edgar->Model Mapping

Feature Distribution

Change over Time